E11.40 (Type 2, unspecified neuropathy), E11.41 (mononeuropathy), E11.42 (polyneuropathy, most common), E11.43 (autonomic neuropathy)
This product must be used under medical supervision
Medical records showing that doctors prescribed Wegovy to you, with usage dates and reasons for the prescription
As research continues to unfold, we may soon see these medications being used to treat a variety of conditions, significantly enhancing patient outcomes and quality of life
Muscle cramps during GLP-1 therapy are typically caused by indirect factors including electrolyte depletion (especially magnesium and potassium) from gastrointestinal side effects, dehydration from reduced fluid intake or vomiting/diarrhea, rapid weight loss with some lean mass reduction, and increased physical activity exceeding current conditioning levels
doi: 10.3390/ijms23168924 100 MutoEOkadaTYamanakaTUchinoHInazuMLicochalconeE